Drug-eluting stents in large coronary vessels improve both safety and efficacy compared with bare-metal stents in women: a pooled analysis of the BASKET-PROVE I and II trials.
Louise Hougesen BjerkingKim Wadt HansenRikke SørensenEva PrescottTor Biering-SørensenRaban JegerChristoph KaiserMatthias PfistererSøren GalatiusPublished in: Open heart (2019)
In patients requiring stenting of large coronary arteries, DES were associated with improved safety in women and superior efficacy in both sexes as compared with BMS.
Keyphrases
- polycystic ovary syndrome
- coronary artery disease
- coronary artery
- end stage renal disease
- ejection fraction
- newly diagnosed
- pregnancy outcomes
- aortic stenosis
- prognostic factors
- peritoneal dialysis
- cervical cancer screening
- metabolic syndrome
- left ventricular
- patient reported outcomes
- breast cancer risk
- acute coronary syndrome
- blood flow
- electronic health record